about
Early origins of heart disease: low birth weight and determinants of cardiomyocyte endowmentMaternal Nutrient Restriction Alters Ca2+ Handling Properties and Contractile Function of Isolated Left Ventricle Bundles in Male But Not Female Juvenile RatsMethodological challenges in using routinely collected health data to investigate long-term effects of medication use during pregnancy.Impact of embryo number and maternal undernutrition around the time of conception on insulin signaling and gluconeogenic factors and microRNAs in the liver of fetal sheepEffects of Maternal Hypoxia during Pregnancy on Bone Development in Offspring: A Guinea Pig Model.Intrauterine growth restriction and differential patterns of hepatic growth and expression of IGF1, PCK2, and HSDL1 mRNA in the sheep fetus in late gestation.Gene expression allelic imbalance in ovine brown adipose tissue impacts energy homeostasis.Embryo number and periconceptional undernutrition in the sheep have differential effects on adrenal epigenotype, growth, and development.Exposed or not exposed? Exploring exposure classification in studies using administrative data to investigate outcomes following medication use during pregnancy.Placental adaptations in growth restriction.Chronic hypoxemia in late gestation decreases cardiomyocyte number but does not change expression of hypoxia-responsive genes.Differential effects of exposure to maternal obesity or maternal weight loss during the periconceptional period in the sheep on insulin signalling molecules in skeletal muscle of the offspring at 4 months of age.The periconceptional environment and cardiovascular disease: does in vitro embryo culture and transfer influence cardiovascular development and health?IGF-2R-Gαq signaling and cardiac hypertrophy in the low-birth-weight lamb.Low birth weight activates the renin-angiotensin system, but limits cardiac angiogenesis in early postnatal life.Maternal obesity and the early origins of childhood obesity: weighing up the benefits and costs of maternal weight loss in the periconceptional period for the offspring.Regulation of microRNA during cardiomyocyte maturation in sheep.Antenatal steroids and the IUGR fetus: are exposure and physiological effects on the lung and cardiovascular system the same as in normally grown fetuses?Impact of maternal undernutrition around the time of conception on factors regulating hepatic lipid metabolism and microRNAs in singleton and twin fetusesBasic experimental and clinical advances in the mechanisms underlying abnormal pregnancy outcomes.Antidepressant use and gestational hypertension: does evidence support causality?Recent developments on the role of epigenetics in obesity and metabolic diseaseSheep models of intrauterine growth restriction: fetal adaptations and consequences.Maternal dietary restriction during the periconceptional period in normal-weight or obese ewes results in adrenocortical hypertrophy, an up-regulation of the JAK/STAT and down-regulation of the IGF1R signaling pathways in the adrenal of the postnataThe fetal sheep lung does not respond to cortisol infusion during the late canalicular phase of development.Antenatal glucocorticoid treatment of the growth-restricted fetus: benefit or cost?Exposure to rosiglitazone, a PPAR-γ agonist, in late gestation reduces the abundance of factors regulating cardiac metabolism and cardiomyocyte size in the sheep fetus.Early restriction of placental growth results in placental structural and gene expression changes in late gestation independent of fetal hypoxemia.Periconceptional nutrition and the early programming of a life of obesity or adversity.Prenatal development of the pulmonary surfactant system and the influence of hypoxia.Investigating outcomes associated with medication use during pregnancy: a review of methodological challenges and observational study designs.Long term impact of prenatal exposure to SSRIs on growth and body weight in childhood: evidence from animal and human studies.Early origins of heart disease: low birth weight and the role of the insulin-like growth factor system in cardiac hypertrophy.Regulation of fetal lung development in response to maternal overnutrition.Epigenetics and human obesity.The early origins of obesity and insulin resistance: timing, programming and mechanisms.Investigating Intracellular Localisation and Cytotoxicity Trends for Neutral and Cationic Iridium Tetrazolato Complexes in Live Cells.Evolution, Development, and Function of the Pulmonary Surfactant System in Normal and Perturbed Environments.Risk of Respiratory Distress Syndrome and Efficacy of Glucocorticoids: Are They the Same in the Normally Grown and Growth-Restricted Infant?A review of fundamental principles for animal models of DOHaD research: an Australian perspective.
P50
Q28254243-C619B01A-5617-4124-84D9-01C05FC9B975Q28548519-81D33ADD-CFBA-46B4-A693-A7BC913E10EDQ30840124-A965BE44-E0FD-4FC5-B3B6-1489846BEE66Q33568682-88BEEC32-EFB4-4FB8-97EC-AD328D707E70Q33735847-3B32C565-02C0-4F7C-9790-9FA318B17ABFQ33770580-B714498E-FCA8-4FA7-8867-39501B51008AQ33860307-CA18A77E-7623-4664-9B22-A0DC26C8046DQ33913103-86C19361-D051-41E0-BEBB-EA6E441271A8Q34073546-E397C4A7-351B-497B-B50A-7914B2C5FBC0Q35003807-F202267B-EE5F-49B0-AED0-A873AA16F193Q35026175-33EF2833-A8FA-4642-9575-D80D5B08044DQ35080996-ED92237F-DA5F-437F-A329-6223FC4B050BQ35227826-45C7D304-3A1F-404E-934D-9A94C4272646Q35275486-111F5DB3-4B6A-4123-ABDE-CC9F9775C8CBQ35363488-D24A9943-CE8D-43FC-84D0-EDC0EDDC5BABQ35607176-F4001064-F461-4CA0-B23F-D992BCD7AA7EQ35704292-ECBCC1DD-928E-420A-9D7C-711090BE26CDQ36440253-E7E185F4-C85A-4B6A-9048-40F8447C367FQ36480300-74045C10-B59B-4AE5-9F3C-87D5E782E609Q36640887-2D008102-0E45-4E26-BE68-38BFAAD9A6CDQ36793021-7FFCCB67-4B38-4C56-868A-D0F705CFF6FAQ37084777-23FAF2F8-432D-465F-B5BD-E3D8A2DF4E08Q37171070-CE2972B5-E351-4565-98E6-D99B9415891BQ37331095-09994C6F-8E98-41DA-A50F-72098CCB4E5BQ37411044-2EDB6574-9D89-4482-B5B5-B2B035B8ED73Q37411884-ACA75C35-10C1-457E-8B52-104B5ECD395FQ37629364-A59210DD-5091-4E8D-A84E-6B6858FB6210Q37710682-D48D88EE-0622-4224-B032-D8E96824AE98Q37822129-6BACD323-A652-4D2F-B2E0-4797314E83D1Q37885031-64A6BB05-B80A-47CC-991F-C4D978678DCFQ37983659-D0B3C9FC-13F9-44E6-89CD-0A96E4BE24D4Q37995464-15C24851-D590-421C-B5FA-C7274515D0DBQ38024826-23BFF2A4-760C-469A-861D-C2B975BF5C9EQ38137247-5E921D7C-9440-40FC-881A-78694B15D83DQ38190867-CB63AD61-AE7F-4B41-B637-59ED85819BE4Q38586447-EFC3B241-6BAC-49EA-A74E-2AC30F8E0C9AQ38646077-E8ADF875-EB14-4F37-9C57-3996DA5F1A0BQ38693287-80C1A583-7E40-4D13-80C8-5B99ED335A03Q38934321-E33ABE98-BBE2-40BA-840E-9958AF949AF9Q38968782-C6147A94-4834-4866-8EA4-563CF76C49C6
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Janna L. Morrison
@ast
Janna L. Morrison
@en
Janna L. Morrison
@es
Janna L. Morrison
@nl
Janna L. Morrison
@sl
type
label
Janna L. Morrison
@ast
Janna L. Morrison
@en
Janna L. Morrison
@es
Janna L. Morrison
@nl
Janna L. Morrison
@sl
altLabel
Janna Leigh Morrison
@en
prefLabel
Janna L. Morrison
@ast
Janna L. Morrison
@en
Janna L. Morrison
@es
Janna L. Morrison
@nl
Janna L. Morrison
@sl
P1053
B-8308-2009
P106
P1153
7403197016
P21
P2798
P31
P3829
P496
0000-0002-8602-8519